Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: The case of the aryl hydrocarbon receptor

Toxicology and Applied Pharmacology

Volumn 207, Issue 2 SUPPL., 2005, Pages 43-51

  Okey, Allan B ^a   Franc, Monique A ^a   Moffat, Ivy D ^a   Tijet, Nathalie ^a   Boutros, Paul C ^a   Korkalainen, Merja ^b   Tuomisto, Jouko ^d   Pohjanvirta, Raimo ^b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATL VET AND FOOD RES INSTITUTE   (Finland)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Gene expression; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AMINO ACID; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CELL NUCLEUS RECEPTOR; CHLORPHENOTANE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DIOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID; GLUCURONOSYLTRANSFERASE 1A1; LIGAND; PESTICIDE; RETINOL; STEROID RECEPTOR; XENOBIOTIC AGENT;

ACUTE TOXICITY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BINDING AFFINITY; BONE MARROW SUPPRESSION; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONFERENCE PAPER; FATTY ACID BLOOD LEVEL; FETOTOXICITY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HEPATIC PORPHYRIA; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE DEFICIENCY; INCISOR; LETHALITY; LIGAND BINDING; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER TOXICITY; METABOLITE; MOUSE STRAIN; NONHUMAN; POLLUTANT; POLLUTION; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN TARGETING; RAT STRAIN; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; STRAIN DIFFERENCE; STRUCTURAL GENOMICS; TERATOGENESIS; TERATOGENICITY; THYMUS ATROPHY; TOOTH DISEASE; TOXICITY; TOXICOKINETICS; TRANSACTIVATION; TRANSCRIPTION REGULATION; WASTING SYNDROME; XENOBIOTIC METABOLISM;

EID: 24644461253     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2004.12.028     Document Type: Conference Paper

References (67)

1. F. Andreola, D.F. Calvisi, G. Elizondo, S.B. Jakowlew, J. Mariano, F.J. Gonzalez, and L.M. De Luca Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion Hepatology 39 2004 157 166
2. T. Baba, J. Mimura, K. Gradin, A. Kuroiwa, T. Watanabe, Y. Matsuda, J. Inazawa, K. Sogawa, and Y. Fujii-Kuriyama Structure and expression of the Ah receptor repressor gene J. Biol. Chem. 276 2001 33101 33110
3. L.S. Birnbaum, and J. Tuomisto Non-carcinogenic effects of TCDD in animals Food Addit. Contam. 17 2000 275 288
4. P.C. Boutros, I.D. Moffat, M.A. Franc, N. Tijet, J. Tuomisto, R. Pohjanvirta, and A.B. Okey Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting Biochem. Biophys. Res. Commun. 321 2004 707 715
5. M.K. Bunger, S.M. Moran, E. Glover, T.L. Thomae, G.P. Lahvis, B.C. Lin, and C.A. Bradfield Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the Aryl hydrocarbon receptor J. Biol. Chem. 278 2003 17767 17774
6. S. Cauchi, I. Stucker, C. Solas, P. Laurent-Puig, S. Cenee, D. Hemon, M. Jacquet, P. Kremers, P. Beaune, and L. Massaad-Massade Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer Carcinogenesis 22 2001 1819 1824
7. C. Cheung, T.E. Akiyama, J.M. Ward, C.J. Nicol, L. Feigenbaum, C. Vinson, and F.J. Gonzalez Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha Cancer Res. 64 2004 3849 3854
8. M.S. Denison, and S.R. Nagy Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals Annu. Rev. Pharmacol. Toxicol. 43 2003 309 334
9. M. Ema, N. Ohe, M. Suzuki, J. Mimura, K. Sogawa, S. Ikawa, and Y. Fujii-Kuriyama Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors J. Biol. Chem. 269 1994 27337 27343
10. W.E. Evans, and M.V. Relling Moving towards individualized medicine with pharmacogenomics Nature 429 2004 464 468
11. P.M. Fernandez-Salguero, D.M. Hilbert, S. Rudikoff, J.M. Ward, and F.J. Gonzalez Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity Toxicol. Appl. Pharmacol. 140 1996 173 179
12. F.W. Frueh, K.C. Hayashibara, P.O. Brown, and J.P. Whitlock Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression Toxicol. Lett. 122 2001 189 203
13. N.L. Ge, and C.J. Elferink A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle J. Biol. Chem. 273 1998 22708 22713
14. R.A. Gibbs, G.M. Weinstock, M.L. Metzker, D.M. Muzny, E.J. Sodergren, S. Scherer, G. Scott, D. Steffen, K.C. Worley, P.E. Burch, G. Okwuonu, S. Hines, L. Lewis, C. DeRamo, O. Delgado, S. Dugan-Rocha, G. Miner, M. Morgan, A. Hawes, R. Gill, R.A. Holt, M.D. Adams, P.G. Amanatides, H. Baden-Tillson, M. Barnstead, S. Chin, C.A. Evans, S. Ferriera, C. Fosler, A. Glodek, Z. Gu, D. Jennings, C.L. Kraft, T. Nguyen, C.M. Pfannkoch, C. Sitter, G.G. Sutton, J.C. Venter, T. Woodage, D. Smith, H.M. Lee, E. Gustafson, P. Cahill, A. Kana, L. Doucette-Stamm, K. Weinstock, K. Fechtel, R.B. Weiss, D.M. Dunn, E.D. Green, R.W. Blakesley, G.G. Bouffard, P.J. De Jong, K. Osoegawa, B. Zhu, M. Marra, J. Schein, I. Bosdet, C. Fjell, S. Jones, M. Krzywinski, C. Mathewson, A. Siddiqui, N. Wye, J. McPherson, S. Zhao, C.M. Fraser, J. Shetty, S. Shatsman, K. Geer, Y. Chen, S. Abramzon, W.C. Nierman, P.H. Havlak, R. Chen, K.J. Durbin, A. Egan, Y. Ren, X.Z. Song, B. Li, Y. Liu, X. Qin, S. Cawley, A.J. Cooney, L.M. D'Souza, K. Martin, J.Q. Wu, M.L. Gonzalez-Garay, A.R. Jackson, K.J. Kalafus, M.P. McLeod, A. Milosavljevic, D. Virk, A. Volkov, D.A. Wheeler, Z. Zhang, J.A. Bailey, E.E. Eichler, and E. Tuzun Genome sequence of the Brown Norway rat yields insights into mammalian evolution Nature 428 2004 493 521
15. B. Gottlieb, L. Pinsky, L.K. Beitel, and M. Trifiro Androgen insensitivity Am. J. Med. Genet. 89 1999 210 217
16. Y.Z. Gu, J.B. Hogenesch, and C.A. Bradfield The PAS superfamily: sensors of environmental and developmental signals Annu. Rev. Pharmacol. Toxicol. 40 2000 519 561
17. J. Guo, M. Sartor, S. Karyala, M. Medvedovic, S. Kann, A. Puga, P. Ryan, and C.R. Tomlinson Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice Toxicol. Appl. Pharmacol. 194 2004 79 89
18. M.E. Hahn Aryl hydrocarbon receptors: diversity and evolution Chem.-Biol. Interact. 141 2002 131 160
19. O. Hankinson The aryl hydrocarbon receptor complex Annu. Rev. Pharmacol. Toxicol. 35 1995 307 340
20. P.A. Harper, J.Y. Wong, M.S. Lam, and A.B. Okey Polymorphisms in the human AH receptor Chem.-Biol. Interact. 141 2002 161 187
21. S. Jain, K.M. Dolwick, J.V. Schmidt, and C.A. Bradfield Potent transactivation domains of the Ah receptor and the Ah receptor nuclear translocator map to their carboxyl termini J. Biol. Chem. 269 1994 31518 31524
22. W. Kalow Pharmacogenetics: Heredity and the Response to Drugs 1962 W.B. Saunders Philadelphia
23. S. Karyala, J. Guo, M. Sartor, M. Medvedovic, S. Kann, A. Puga, P. Ryan, and C.R. Tomlinson Different global gene expression profiles in benzo[a]pyrene- and dioxin-treated vascular smooth muscle cells of AHR-knockout and wild-type mice Cardiovasc. Toxicol. 4 2004 47 74
24. K. Kawajiri, J. Watanabe, H. Eguchi, K. Nakachi, C. Kiyohara, and S. Hayashi Polymorphisms of human Ah receptor gene are not involved in lung cancer Pharmacogenetics 5 1995 151 158
25. W.R. Kelce, C.R. Stone, S.C. Laws, L.E. Gray, J.A. Kemppainen, and E.M. Wilson Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist Nature 375 1995 581 585
26. H.P. Ko, S.T. Okino, Q. Ma, and J.P. Whitlock Jr. Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo Mol. Cell. Biol. 17 1997 3497 3507
27. M. Korkalainen, J. Tuomisto, and R. Pohjanvirta Identification of novel splice variants of ARNT and ARNT2 in the rat Biochem. Biophys. Res. Commun. 303 2003 1095 1100
28. M. Korkalainen, J. Tuomisto, and R. Pohjanvirta Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain Biochem. Biophys. Res. Commun. 315 2004 123 131
29. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. van der Saag, B. van der Burg, and J.A. Gustafsson Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 1998 4252 4263
30. M.B. Kumar, P. Ramadoss, R.K. Reen, J.P. Vanden Heuvel, and G.H. Perdew The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity J. Biol. Chem. 276 2001 42302 42310
31. G.P. Lahvis, and C.A. Bradfield Ahr null alleles: distinctive or different? Biochem. Pharmacol. 56 1998 781 787
32. G.P. Lahvis, S.L. Lindell, R.S. Thomas, R.S. McCuskey, C. Murphy, E. Glover, M. Bentz, J. Southard, and C.A. Bradfield Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice Proc. Natl. Acad. Sci. U.S.A. 97 2000 10442 10447
33. J.M. Martinez, C.A. Afshari, P.R. Bushel, A. Masuda, T. Takahashi, and N.J. Walker Differential toxicogenomic responses to 2,3,7,8-tetrachlorodibenzo- p-dioxin in malignant and nonmalignant human airway epithelial cells Toxicol. Sci. 69 2002 409 423
34. J. Mimura, K. Yamashita, K. Nakamura, M. Morita, T.N. Takagi, K. Nakao, M. Ema, K. Sogawa, M. Yasuda, M. Katsuki, and Y. Fujii-Kuriyama Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor Genes Cells 2 1997 645 654
35. T. Moriguchi, H. Motohashi, T. Hosoya, O. Nakajima, S. Takahashi, S. Ohsako, Y. Aoki, N. Nishimura, C. Tohyama, Y. Fujii-Kuriyama, and M. Yamamoto Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse Proc. Natl. Acad. Sci. U.S.A. 100 2003 5652 5657
36. D.W. Nebert The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects Crit. Rev. Toxicol. 20 1989 153 174
37. D.W. Nebert, T.P. Dalton, A.B. Okey, and F.J. Gonzalez Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer J. Biol. Chem. 279 2004 23847 23850
38. Nuclear Receptors Nomenclature Committee A unified nomenclature system for the nuclear receptor superfamily Cell 97 1999 161 163
39. A.B. Okey Enzyme induction in the cytochrome P-450 system Pharmacol. Ther. 45 1990 241 298
40. A.B. Okey Variability in induction of human drug metabolizing enzymes W. Kalow U.A. Meyer R.F. Tyndale Pharmacogenomics 1990 Marcel Dekker New York 157 205
41. A.B. Okey, L.M. Vella, and P.A. Harper Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene Mol. Pharmacol. 35 1989 823 830
42. A.B. Okey, D.S. Riddick, and P.A. Harper The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds Toxicol. Lett. 70 1994 1 22
43. R. Pohjanvirta, and J. Tuomisto Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models Pharmacol. Rev. 46 1994 483 549
44. R. Pohjanvirta, R. Juvonen, S. Karenlampi, H. Raunio, and J. Tuomisto Hepatic Ah-receptor levels and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hepatic microsomal monooxygenase activities in a TCDD-susceptible and -resistant rat strain Toxicol. Appl. Pharmacol. 92 1988 131 140
45. R. Pohjanvirta, J.M.Y. Wong, W. Li, P.A. Harper, J. Tuomisto, and A.B. Okey Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8- tetrachlorodibenzo-p-dioxin-resistant rat strain Mol. Pharmacol. 54 1998 86 93
46. R. Pohjanvirta, M. Viluksela, J.T. Tuomisto, M. Unkila, J. Karasinska, M.-A. Franc, M. Holowenko, J.V. Giannone, P.A. Harper, J. Tuomisto, and A.B. Okey Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains Toxicol. Appl. Pharmacol. 155 1999 82 95
47. A. Poland, E. Glover, and A.S. Kende Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase J. Biol. Chem. 251 1976 4936 4946
48. A. Puga, A. Maier, and M. Medvedovic The transcriptional signature of dioxin in human hepatoma HepG2 cells Biochem. Pharmacol. 60 2000 1129 1142
49. J. Racky, H.J. Schmitz, H.M. Kauffmann, and D. Schrenk Single nucleotide polymorphism analysis and functional characterization of the human Ah receptor (AhR) gene promoter Arch. Biochem. Biophys. 421 2004 91 98
50. D.S. Riddick, C. Lee, A. Bhathena, Y.E. Timsit, P.Y. Cheng, E.T. Morgan, R.A. Prough, S.L. Ripp, K.K. Miller, A. Jahan, and J.Y. Chiang Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals Drug Metab. Dispos. 32 2004 367 375
51. S.H. Safe Endocrine disruptors and human health-is there a problem? An update Environ. Health Perspect. 108 2000 487 493
52. U. Simanainen, J.T. Tuomisto, J. Tuomisto, and M. Viluksela Structure-activity relationships and dose responses of polychlorinated dibenzo-p-dioxins for short-term effects in 2,3,7,8-tetrachlorodibenzo-p-dioxin- resistant and -sensitive rat strains Toxicol. Appl. Pharmacol. 181 2002 38 47
53. U. Simanainen, J.T. Tuomisto, J. Tuomisto, and M. Viluksela Dose-response analysis of short-term effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in three differentially susceptible rat lines Toxicol. Appl. Pharmacol. 187 2003 128 136
54. M.H. Sweeney, and P. Mocarelli Human health effects after exposure to 2,3,7,8-TCDD Food Addit. Contam. 17 2000 303 316
55. T.L. Thomae, E. Glover, and C.A. Bradfield A maternal Ahr null genotype sensitizes embryos to chemical teratogenesis J. Biol. Chem. 279 2004 30189 30194
56. R.S. Thomas, S.G. Penn, K. Holden, C.A. Bradfield, and D.R. Rank Sequence variation and phylogenetic history of the mouse Ahr gene Pharmacogenetics 12 2002 151 163
57. N. Tijet, I.D. Moffat, P.C. Boutros, M.A. Franc, R. Pohjanvirta, J. Tuomisto, and A.B. Okey Responses of multiple P450s and Phase II enzymes to dioxin in rats bearing a large deletion in the transactivation domain of the AH receptor 15th Annual Symposium on Microsomes and Drug Oxidations 2004
58. J.T. Tuomisto, M. Viluksela, R. Pohjanvirta, and J. Tuomisto The AH receptor and a novel gene determine acute toxic responses to TCDD: segregation of the resistant alleles to different rat lines Toxicol. Appl. Pharmacol. 155 1999 71 81
59. S. Uno, T.P. Dalton, P.R. Sinclair, N. Gorman, B. Wang, A.G. Smith, M.L. Miller, H.G. Shertzer, and D.W. Nebert Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria Toxicol. Appl. Pharmacol. 196 2004 410 421
60. M. Viluksela, Y. Bager, J.T. Tuomisto, G. Scheu, M. Unkila, R. Pohjanvirta, S. Flodstrom, V.M. Kosma, J. Maki-Paakkanen, T. Vartiainen, C. Klimm, K.W. Schramm, L. Warngard, and J. Tuomisto Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains Cancer Res. 60 2000 6911 6920
61. J.A. Walisser, M.K. Bunger, E. Glover, E.B. Harstad, and C.A. Bradfield Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele J. Biol. Chem. 279 2004 16326 16331
62. R. Weinshilboum Inheritance and drug response N. Engl. J. Med. 348 2003 529 537
63. J.M. Wong, A.B. Okey, and P.A. Harper Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction Biochem. Biophys. Res. Commun. 288 2001 990 996
64. M.E. Wyde, E. Bartolucci, A. Ueda, H. Zhang, B. Yan, M. Negishi, and L. You The environmental pollutant 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene induces rat hepatic cytochrome P450 2B and 3A expression through the constitutive androstane receptor and pregnane X receptor Mol. Pharmacol. 64 2003 474 481
65. T. Zacharewski Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays Environ. Health Perspect. 106 Suppl. 2 1998 577 582
66. A. Zeytun, R. McKallip, M. Fisher, I. Camacho, M. Nagarkatti, and P. Nagarkatti Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays Toxicology 178 2002 241
67. S.L. Zheng, W. Zheng, B.L. Chang, X.O. Shu, Q. Cai, H. Yu, Q. Dai, J. Xu, and Y.T. Gao Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women Cancer Res. 63 2003 7624 7629